Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,769
archived clinical trials in
Migraine Headaches

Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Savannah Neurology Specialists
mi
from
Savannah, GA
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Savannah Neurology Specialists
mi
from
Savannah, GA
Click here to add this to my saved trials
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Hassman Research Institute
mi
from
Berlin, NJ
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Hassman Research Institute
mi
from
Berlin, NJ
Click here to add this to my saved trials
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Click here to add this to my saved trials
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
SPRI Clinical Trials LLC
mi
from
Brooklyn, NY
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
SPRI Clinical Trials LLC
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
mi
from
Jamaica, NY
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
mi
from
Jamaica, NY
Click here to add this to my saved trials
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Red Star Research, LLC
mi
from
Lake Jackson, TX
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Red Star Research, LLC
mi
from
Lake Jackson, TX
Click here to add this to my saved trials
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Woodland Research Northwest
mi
from
Rogers, AR
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Woodland Research Northwest
mi
from
Rogers, AR
Click here to add this to my saved trials
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Montefiore Heachache Center
mi
from
Bronx, NY
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Montefiore Heachache Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Optimus Medical Group
mi
from
San Francisco, CA
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Optimus Medical Group
mi
from
San Francisco, CA
Click here to add this to my saved trials
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Renstar Medical Research
mi
from
Ocala, FL
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Renstar Medical Research
mi
from
Ocala, FL
Click here to add this to my saved trials
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Clinical Research Institute Inc.
mi
from
Minneapolis, MN
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Clinical Research Institute Inc.
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Sundance Clinical Research, LLC
mi
from
Saint Louis, MO
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Sundance Clinical Research, LLC
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Fieve Clinical Research, Inc.
mi
from
Scranton, PA
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Fieve Clinical Research, Inc.
mi
from
Scranton, PA
Click here to add this to my saved trials
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Ventavia Research Group, LLC
mi
from
Fort Worth, TX
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Ventavia Research Group, LLC
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Ormond Medical Arts Pharmaceutical Research
mi
from
Ormond Beach, FL
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Ormond Medical Arts Pharmaceutical Research
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Clinical Research Insitute
mi
from
Plymouth, MN
Open Label Safety Study in Acute Treatment of Migraine
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Clinical Research Insitute
mi
from
Plymouth, MN
Click here to add this to my saved trials
Efficacy and Safety of IONIS-PKKRx for Preventive Treatment of Chronic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of ISIS 546254 for Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  12/31/1969
StudyMetrix
mi
from
Saint Peters, MO
Efficacy and Safety of IONIS-PKKRx for Preventive Treatment of Chronic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of ISIS 546254 for Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 12/31/1969
StudyMetrix
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Efficacy and Safety of IONIS-PKKRx for Preventive Treatment of Chronic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of ISIS 546254 for Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated:  12/31/1969
Clinvest Research
mi
from
Springfield, MO
Efficacy and Safety of IONIS-PKKRx for Preventive Treatment of Chronic Migraine
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of ISIS 546254 for Preventive Treatment of Chronic Migraine
Status: Enrolling
Updated: 12/31/1969
Clinvest Research
mi
from
Springfield, MO
Click here to add this to my saved trials
Staccato Prochlorperazine Single Dose PK Study
Tolerability, Safety and Pharmacokinetics of a Single Dose of Staccato™ Prochlorperazine for Inhalation in Normal, Healthy Volunteers
Status: Enrolling
Updated:  12/31/1969
PPD Phase I Clinic
mi
from
Austin, TX
Staccato Prochlorperazine Single Dose PK Study
Tolerability, Safety and Pharmacokinetics of a Single Dose of Staccato™ Prochlorperazine for Inhalation in Normal, Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
PPD Phase I Clinic
mi
from
Austin, TX
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10147
mi
from
Long Beach, CA
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10147
mi
from
Long Beach, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site
mi
from
San Diego, CA
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10172
mi
from
Colorado Springs, CO
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10172
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10715
mi
from
Maitland, FL
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10715
mi
from
Maitland, FL
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10269
mi
from
Orlando, FL
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10269
mi
from
Orlando, FL
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 01
mi
from
Decatur, GA
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 01
mi
from
Decatur, GA
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10116
mi
from
Meridian, ID
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10116
mi
from
Meridian, ID
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 1367
mi
from
Chicago, IL
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 1367
mi
from
Chicago, IL
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10345
mi
from
Evanston, IL
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10345
mi
from
Evanston, IL
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 14747
mi
from
Pikesville, MD
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 14747
mi
from
Pikesville, MD
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 603
mi
from
Watertown, MA
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 603
mi
from
Watertown, MA
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 098
mi
from
Ann Arbor, MI
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 098
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10150
mi
from
Omaha, NE
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10150
mi
from
Omaha, NE
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10409
mi
from
Berlin, NJ
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10409
mi
from
Berlin, NJ
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site
mi
from
Albuquerque, NM
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13576
mi
from
Amherst, NY
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13576
mi
from
Amherst, NY
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13544
mi
from
Greensboro, NC
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13544
mi
from
Greensboro, NC
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site
mi
from
Raleigh, NC
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10511
mi
from
Warwick, RI
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10511
mi
from
Warwick, RI
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 084
mi
from
Memphis, TN
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 084
mi
from
Memphis, TN
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 1310
mi
from
Nashville, TN
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 1310
mi
from
Nashville, TN
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10405
mi
from
Austin, TX
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10405
mi
from
Austin, TX
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13581
mi
from
West Jordan, UT
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13581
mi
from
West Jordan, UT
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 37092
mi
from
Brugge,
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 37092
mi
from
Brugge,
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10271
mi
from
Santa Monica, CA
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10271
mi
from
Santa Monica, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10235
mi
from
Fall River, MA
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10235
mi
from
Fall River, MA
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10675
mi
from
Huntsville, AL
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10675
mi
from
Huntsville, AL
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site
mi
from
Louisville, KY
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site
mi
from
Louisville, KY
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10531
mi
from
Plymouth, MN
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10531
mi
from
Plymouth, MN
Click here to add this to my saved trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10181
mi
from
Lincoln, RI
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Study With an Open-Label Period to Evaluate the Efficacy and Safety of Fremanezumab for the Prophylactic Treatment of Migraine in Patients With Inadequate Response to Prior Preventive Treatments
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10181
mi
from
Lincoln, RI
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
StudyMetrix Research
mi
from
Saint Peters, MO
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
StudyMetrix Research
mi
from
Saint Peters, MO
Click here to add this to my saved trials